Dividends Calendar Earnings Calendar
ALVR

ALVR | Allovir Inc

Allovir Inc
Category: Healthcare
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume: 74.3M
  • Market Cap: 258.82M
  • Prev closed: 19.89
  • Open: 19.86
  • High: 20.3
  • Low: 19.63
  • 52 week low: 16.66
  • 52 week high: 48.96
  • Dividends:No Dividends

Next ER: February 16, 2023  Before Market Opens



Top Stories (ALVR)

    Company Profile

    AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company?s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir?s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    February 9, 2023
    November 15, 2022
    September 7, 2022- / -0.7027- / -
    August 4, 2022-0.69 / -0.7027- / -
    May 5, 2022-0.69 / -0.7375- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jul 27, 2022 5.16 5.03
    6.32
    4.92
    5.92M 11.69%
    Jul 26, 2022 4.62 4.60
    4.72
    4.40
    131.76K 0%
    Jul 25, 2022 4.62 4.95
    5.04
    4.50
    144.06K -6.85%
    Jul 22, 2022 4.96 5.35
    5.43
    4.92
    139.83K -7.64%
    Jul 21, 2022 5.37 5.32
    5.54
    5.20
    77.18K 0.75%
    Jul 20, 2022 5.33 5.14
    5.55
    5.14
    144.42K 3.90%
    Jul 19, 2022 5.13 4.94
    5.46
    4.82
    247.75K 5.34%
    Jul 18, 2022 4.87 4.98
    5.30
    4.81
    138.87K -3.37%
    Jul 15, 2022 5.04 5.10
    5.32
    4.82
    95.28K -3.45%
    Jul 14, 2022 5.22 5.17
    5.28
    5.12
    124.52K -1.14%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:32

    News

    News for (ALVR)

    This company doesn't provide a dividend.


    Talk about Allovir Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Feb 16, 2023 (Same day)

    cx amat rmax vale h dnow pbf rs has so hubs kbr 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 80
    HOLD 20
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!